Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Selectis HealthGBCS 41 3-1 Month Momentum % is 53.62% as of Aug. 18, 2026. GuruFocus rates GBCS with a GF Score™ of 41/100 and a GF Value™ of $2.15 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 673 Healthcare Providers & Services companies, Selectis Health ranks better than 97.18% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-18), Selectis Health's 3-1 Month Momentum % is 53.62%.
The industry rank for Selectis Health's 3-1 Month Momentum % or its related term are showing as below:
GBCS's 3-1 Month Momentum % is ranked better than 97.18% of 673
companies
in the Healthcare Providers & Services industry
Industry Median: -2.08
vs GBCS: 53.62
Selectis Health (OTCPK:GBCS) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Selectis Health 3-1 Month Momentum % Related Terms
GBCS vs ADIA, CCM, CDIX: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, Selectis Health's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selectis Health 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Selectis Health's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Selectis Health's 3-1 Month Momentum % falls into.
Selectis Health (OTCPK:GBCS) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selectis Health (GBCS) has a 3-1 Month Momentum % of 53.62% as of Aug. 18, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Selectis Health and its competitors. According to the industry distribution chart, Selectis Health ranks #19 out of 673 companies in the Healthcare Providers & Services industry, placing it in the top 2.8%.
Is Selectis Health's 3-1 Month Momentum % too high?
Selectis Health's current 3-1 Month Momentum % is 53.62%. Based on the distribution chart, Selectis Health ranks #19 out of 673 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Selectis Health has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selectis Health's 3-1 Month Momentum % compare to ADIA and CCM?
According to the Healthcare Providers & Services industry distribution chart, Selectis Health ranks #19 out of 673 companies for 3-1 Month Momentum %. This places Selectis Health in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Selectis Health and its competitors. Selectis Health's current 3-1 Month Momentum % is 53.62%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selectis Health stock overvalued right now?
Based on GuruFocus' analysis, Selectis Health (GBCS) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.15, compared to a current price of $5.60 — trading 160.5% above its estimated fair value. The current 3-1 Month Momentum % is 53.62%. Selectis Health's overall GF Score™ is 41/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Selectis Health (GBCS), the current 3-1 Month Momentum % is 53.62% as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selectis Health (GBCS) Overvalued in 2026?
Based on GuruFocus' analysis, Selectis Health stock appears to be overvalued.
The current stock price of $5.60 is trading 160.5% above its estimated GF Value™ of $2.15.
GuruFocus considers Selectis Health to be Significantly Overvalued.
Key valuation signals for GBCS:
3-1 Month Momentum %: 53.62%
GF Value™: $2.15 vs. price of $5.60 (160.5% above fair value)
No single metric tells the full story. See the GBCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selectis Health Inc owns and operates medical care facilities in the healthcare industry. The company acquires, develops, leases, and manages healthcare real estate and provides healthcare operations through its wholly-owned subsidiaries. The portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. It makes investments within the healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008, which represents investments in senior housing operations, and (vi) owning healthcare operations.
41GF Score
Get the complete analysis for GBCS
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GBCS has been successfully added to your 
